Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127342401 | 12734240 | 1 | I | 20160830 | 20160912 | 20160912 | EXP | US-ASTRAZENECA-2016SE96387 | ASTRAZENECA | 75.00 | YR | M | Y | 0.00000 | 20160913 | PH | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127342401 | 12734240 | 1 | PS | BLOPRESS | CANDESARTAN CILEXETIL | 1 | Oral | GENERIC CANDESARTAN CILEXETIL | U | U | 20838 | TABLET | |||||||
| 127342401 | 12734240 | 2 | SS | BLOPRESS | CANDESARTAN CILEXETIL | 1 | Oral | UNK | U | U | 20838 | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127342401 | 12734240 | 1 | Product used for unknown indication |
| 127342401 | 12734240 | 2 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127342401 | 12734240 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127342401 | 12734240 | Blood creatine phosphokinase increased | |
| 127342401 | 12734240 | Gait disturbance |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |